Table 3.
Descriptive summary of pre-chemotherapy nausea and anxiety by chemotherapy cycle
| Cycle 1 (n = 139) | Cycle 2 (n = 139) | Cycle 3 (n = 138) | Cycle 4 (n = 136) | |||||
|---|---|---|---|---|---|---|---|---|
| Mean score for prechemotherapy nausea, (0–10 NRS) | 0.85 | 0.56; 1.13 | 1.47 | 1.08; 1.85 | 1.64 | 1.26; 2.01 | 1.65 | 1.27; 2.02 |
| Pre-chemotherapy nausea (≥1 NRS) | 29 (20.9%) | 15.8; 27.1 | 48 (34.5%) | 28.2; 41.4 | 51 (36.9%) | 30.5; 43.9 | 55 (40.4%) | 33.8; 47.5 |
| Significant prechemotherapy nausea (≥3 NRS) | 19 (13.7%) | 9.5; 19.2 | 25 (17.9%) | 13.2; 23.9 | 37 (26.8%) | 21.1; 33.4 | 34 (25%) | 19.4; 31.6 |
| Mean score for prechemotherapy anxiety, (0–10 NRS) | 2.68 | 2.25; 3.10 | 1.81 | 1.46; 2.16 | 1.97 | 1.62; 2.33 | 2.03 | 1.66; 2.40 |
| Pre-chemotherapy anxiety (≥1 NRS) | 85 (61.2%) | 54.2; 67.7 | 66 (47.5%) | 40.6; 54.4 | 74 (53.6%) | 46.6; 60.5 | 72 (52.9%) | 45.9; 59.9 |
| Significant prechemotherapy anxiety (≥3 NRS) | 58 (41.7%) | 35.1; 48.7 | 40 (28.8%) | 22.9; 35.5 | 43 (31.2%) | 25.1; 37.9 | 48 (35.3%) | 28.9; 42.3 |
CI confidence interval, NRS numerical rating scale (with 10 being the most severe)
Data are reported with 90% CI